IV Lidocaine Analgesia in Pediatric Scoliosis Surgery

PHASE3CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

December 18, 2019

Primary Completion Date

May 10, 2024

Study Completion Date

May 10, 2024

Conditions
Scoliosis; AdolescenceAnesthesia Recovery Period
Interventions
DRUG

Lidocaine

Intervention group (A) will receive P-IVLT in addition to the standard multimodal analgesia. P-IVLT will consist of 1 mg/kg bolus at start of anesthesia (T0), followed by 2 mg·kg-1·hr-1 infusion for 8 hours (T1), then continued at 1 mg·kg-1·hr-1 infusion thereafter and postoperatively until T0 + 48 hours (T2).

DRUG

Saline Solution

Control group (B) will receive a placebo (0.9% sodium chloride also known as normal saline), made to mimic the intervention protocol described above, in addition to the standard multimodal analgesia.

Trial Locations (1)

V6H 3V4

BC Children's Hospital - Department of Anesthesia, Vancouver

All Listed Sponsors
lead

University of British Columbia

OTHER

NCT04069169 - IV Lidocaine Analgesia in Pediatric Scoliosis Surgery | Biotech Hunter | Biotech Hunter